August 25, 2010
ViewRay Secures Series C Financing

August 19, 2010
Acceleron Pharma Receives FDA Orphan Designation for ACE-031 for the Treatment of Duchenne Muscular Dystrophy

August 16, 2010
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO

August 10, 2010
Amarin Reports Q2 2010 Results

August 03, 2010
Siteman Cancer Center to Receive First ViewRay Radiation Therapy System

July 30, 2010
Complete Genomics Files Registration Statement for Proposed Initial Public Offering

July 29, 2010
Insulet Corp. Revenue Increases 57% Year over Year; More than 20,000 Customers Now Using the OmniPod System

July 28, 2010
Response Biomedical Corporation Closes $8 Million Private Placement

July 26, 2010
Cerenis Therapeutics raises EUR 40 million in series C financing

July 23, 2010
NxStage Reports Record Second Quarter 2010 Financial Results and Raises Revenue Guidance For 2010

July 09, 2010
Adimab Announces Fifth Major Pharma Partnership in First Year After Launch

June 15, 2010
Pieris Initiates Phase I Clinical Trial for Lead Anticalin Compound

April 12, 2010
Inhibitex Reports Results of Interim Analysis of Phase II Clinical Trial of FV-100

April 08, 2010
ChemoCentryx Identifies Novel Small Molecule ChemR23 Antagonist for the Treatment of Inflammatory Diseases

March 29, 2010
Enobia Presents Results from Hypophosphatasia Impact Patient Survey

February 25, 2010
NxStage Reports Fourth Quarter and Full-Year 2009 Financial Results That Exceed Company Guidance

February 09, 2010
Insulet Reports Fourth Quarter Results: FY 2009 Revenue Increases 83%

January 28, 2010
ChemoCentryx Initiates Clinical Trial of CCX168

January 27, 2010
Supernus Announces Positive Results from Phase IIa Clinical Trial for SPN 810

January 22, 2010
Complete Genomics Named a Red Herring Global 100 Award Winner

January 11, 2010
ForteBio Launches New Dip and Read™ Residual Protein A Detection Kit

January 11, 2010
Volcano Corporation Announces Record Revenues for Fourth Quarter 2009

January 04, 2010
Pieris Appoints a new CEO

December 21, 2009
Athersys Enters Into Global Agreement With Pfizer to Develop Release and Market MultiStem(R)

December 18, 2009
Ambit Biosciences and Astellas Enter Strategic Partnership

November 05, 2009
Complete Genomics Publishes in Science on Low-Cost Sequencing of Three Human Genomes

November 05, 2009
Volcano Reports 22 Percent Increase in Third Quarter Revenues

October 01, 2009
Adimab Completes Series D Financing Led by Google Ventures

September 16, 2009
PharmAbcine Closes USD $6 Million Series A Financing

September 14, 2009
Enobia Announces Positive Clinical Results with an Enzyme Replacement Therapy for Hypophosphatasia

August 24, 2009
Complete Genomics Secures $45 Million in Series D Funding

August 10, 2009
Enobia Raises US$50M from Current Investors in Series C Financing

August 05, 2009
NxStage Reports Second Quarter 2009 Financial Results, Revenues Increase 15%

June 17, 2009
NxStage(R) Announces Medisystems(R) Bloodline Distribution Agreement with Gambro

June 11, 2009
Enobia Announces Positive Interim Clinical Results with ENB-0040

June 10, 2009
InteKrin Therapeutics Announces INT131 Phase 2a Results at the 2009 American Diabetes Association Annual Meeting

May 20, 2009
Aragon Pharmaceuticals Announces $8 Million Series A Financing

May 05, 2009
Volcano Reports First Quarter Revenues of $49.0 Million; IVUS and FM Businesses Grew 24 Percent

April 14, 2009
ViewRay Announces Partnership with Siemens AG

April 14, 2009
ViewRay Closes $15 Million Tranche of Series B Financing

April 06, 2009
Cerapedics Closes $15 Million Series B Financing

March 11, 2009
InteKrin Therapeutics Announces Enrollment Completion of Phase 2b Study

March 09, 2009
Igenica appoints Dr. Mike Rothe as CEO after closing Series A financing

March 03, 2009
ENOBIA COMPLETES TARGET ENROLLMENT IN CLINICAL TRIAL FOR INFANTILE HYPOPHOSPHATASIA

February 10, 2009
CERENIS THERAPEUTICS RECEIVES €2.5 MILLION INVESTMENT FROM FRENCH GOVERNMENT THROUGH OSEO

January 30, 2009
Supernus Initiates Phase IIa Clinical Trial for SPN810 in Conduct Disorder

January 13, 2009
Acceleron Introduces Breakthrough Program for Treatment of Anemia

December 23, 2008
Volcano Announces Acquisition of Axsun Technologies, Inc.

December 18, 2008
ARYx Therapeutics, Inc. Announces Successful Outcome of Atrial Fibrillation Clinical Trial on ATI-2042

December 17, 2008
Supernus Initiates Phase III Clinical Trial for Epliga™ in Refractory Partial Onset Epileptic Seizures

December 03, 2008
Acceleron to Present ACE-011 Data at the 50th Annual Meeting of the American Society of Hematology

November 05, 2008
Volcano Reports 40 Percent Growth in Quarterly Revenues

October 20, 2008
Acceleron Initiates Phase 1 Clinical Trial for ACE-031 to Treat Diseases Involving Muscle Loss

September 23, 2008
ForteBio Closes $25 Million in Series C Financing Led by OrbiMed

September 19, 2008
Enobia Receives FDA Orphan Drug Designation for ENB-0040

September 09, 2008
Biodel Announces Preliminary Results of Pivotal Phase III Clinical Trials for VIAject

August 05, 2008
NxStage Reports Second Quarter 2008 Financial Results

August 05, 2008
Volcano Reports 40 Percent Increase in Quarterly Revenues

July 22, 2008
Amarin Proceeding to Phase 3 with AMR101 for Hypertriglyceridemia

July 17, 2008
MacroGenics Acquires Raven Biotechnologies

May 23, 2008
NxStage Announces $43 Million Private Placement

May 22, 2008
Amarin announces completion of $60 million private placement.

May 06, 2008
Apoptos raises $28 million in Series A financing

April 15, 2008
Pacira Expands Collaboration with Amylin Pharmaceuticals

March 27, 2008
Pieris raises $38 million in Series B financing round

March 04, 2008
VIVUS Completes Enrollment in EQUATE (OB-301) Trial

February 27, 2008
Athersys Announces Results for Phase 1 Study of Its Novel Obesity Drug

February 25, 2008
InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131

February 20, 2008
Acceleron Pharma Announces Global Collaboration with Celgene Corporation

February 12, 2008
Volcano Reports 35 Percent Increase in Quarterly Revenues

February 04, 2008
Affimed Increases Series B Financing in Second Closing to Euro 30 Million

January 22, 2008
Teva to Acquire CoGenesys

January 21, 2008
ViewRay Raises $25 Million in Series B Financing

January 16, 2008
Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate Its Diclofenac Patch for Mild to Moderate Pain

December 18, 2007
EPIX Pharmaceuticals Reports Compelling Clinical Results for PRX-03140 in Alzheimer's Disease

December 08, 2007
Ambit Biosciences Presents Data on AC220 in Acute Myeloid Leukemia

November 27, 2007
Astellas to Acquire Agensys, Inc.

November 08, 2007
InteKrin Appoints Former Amgen Clinical Development Executive Chief Medical Officer

November 07, 2007
Aryx Announces Pricing of its Initial Public Offering

October 31, 2007
Ambit Biosciences Announces Second Expansion of Collaboration with Bristol-Myers Squibb

October 18, 2007
Athersys' Registration Statement Declared Effective

October 18, 2007
Lilly and MacroGenics Announce Major Collaboration Agreement

October 10, 2007
Targanta Announces Pricing of Initial Public Offering

October 09, 2007
Biodel Inc. Receives Notice of Issuance for U.S. Patent Covering Lead Product Candidates

October 02, 2007
Cerimon Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch

September 10, 2007
Enobia Raises $40.1 Million Series B Financing

August 30, 2007
ARYx Therapeutics Files Registration Statement for Initial Public Offering

August 20, 2007
NeurAxon Announces $32 Million Series B Financing

August 09, 2007
BIOCRYST COMPLETES $65.3 MILLION PRIVATE PLACEMENT FINANCING

August 07, 2007
EPIX Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of First-in-Class 5-HT2B Antagonist

August 06, 2007
Acceleron Pharma to Present ACE-011 Bone Growth Data

July 12, 2007
Agensys Raises $41 Million

June 26, 2007
Acceleron’s ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model

June 21, 2007
VIVUS Completes End of Phase 2 Meeting with the FDA for Qnexa

June 15, 2007
Biodel Inc. Announces USPTO Office Action Indicating Allowability of Certain Claims

May 23, 2007
ChemoCentryx Presents Positive Phase 2 Clinical Data for Traficet-EN® in Crohn's Disease

May 17, 2007
Biodel Announces Completion of Public Offering

May 15, 2007
Insulet Announces Pricing of Initial Public Offering

May 07, 2007
Volcano Corporation Reports 49 Percent Increase in Revenues

April 25, 2007
XenoPort Reports Positive Top-Line Phase 3 Trial Results

April 18, 2007
AESTHETICS AND PLASTIC SURGERY COMPANY SIENTRA INC. RAISES $85 MILLION IN SERIES B FINANCING

April 18, 2007
Avanir Announces Positive Results of Phase III Study for Zenvia in Diabetic Neuropathic Pain

April 18, 2007
EPIX Pharmaceuticals Announces Statistically Significant Results in Cognitive Function from Phase 1b Clinical Trial

April 04, 2007
Affimed Closes $32 million Series B financing

April 04, 2007
Cerimon Pharmaceuticals Initiates Global Phase 2b Study of Basiliximab

April 04, 2007
Volcano Corporation Reports Use of IVUS Increasing as Physicians Refocus on Stent Technique

April 03, 2007
Volcano Corporation and ev3 Inc. Announce Joint Marketing and Distribution Agreement

March 30, 2007
VIVUS Agrees to Sell EvaMist for up to $150 Million

March 27, 2007
CoGenesys Expands Clinical Programs With Initiation of Phase 1-2 Trial of Neugranin

March 05, 2007
BIOCRYST AND SHIONOGI ESTABLISH COLLABORATION IN JAPAN

February 13, 2007
Volcano Corporation Reports Record Quarterly Revenues; Total Year Revenues Reach $103 Million

February 08, 2007
GlaxoSmithKline and XenoPort Announce Agreement on Late-Stage Compound for RLS and Neuropathic Pain

January 11, 2007
InteKrin Therapeutics Secures $23 Million Venture Financing

January 10, 2007
InteKrin Therapeutics Licenses Diabetes Product from Amgen

January 04, 2007
BioCryst Awarded $102.6 Million from U.S. Dept. Of Health and Human Services to Develop Peramivir for Seasonal and Pandemic Influenza

January 03, 2007
MacroGenics and JDRF Form Partnership to Support Pivotal Phase II/III Clinical Trial of Anti-CD3 Monoclonal Antibody